SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-046392
Filing Date
2023-12-28
Accepted
2023-12-28 17:02:41
Documents
14
Period of Report
2023-12-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44466
2 ex4-1.htm EX-4.1 18318
  Complete submission text file 0001493152-23-046392.txt   238069

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE invo-20231228.xsd EX-101.SCH 3033
4 XBRL LABEL FILE invo-20231228_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE invo-20231228_pre.xml EX-101.PRE 22371
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3221
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39701 | Film No.: 231523363
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)